Yale Bulletin and Calendar

November 9, 2007|Volume 36, Number 10


BULLETIN HOME

VISITING ON CAMPUS

CALENDAR OF EVENTS

IN THE NEWS

BULLETIN BOARD

CLASSIFIED ADS


SEARCH ARCHIVES

DEADLINES

DOWNLOAD FORMS

BULLETIN STAFF


PUBLIC AFFAIRS HOME

NEWS RELEASES

E-MAIL US


YALE HOME PAGE


Program to look at company developing innovative treatment for varicose veins

The Yale BioHaven Entrepreneurship Seminars series continues its fall schedule with a program on Vascular Insights LLC, a New Haven-area start-up company founded to develop, manufacture and market the Clari­Vein-VA™ vascular ablation devices used to treat varicose vein disease.

The presentation will take place on Tuesday, Nov. 13, 4-5 p.m. in the Anlyan Center auditorium, Yale School of Medicine, 300 Cedar St. The series is organized by the Yale Office of Cooperative Research and Connecticut United for Research Excellence (CURE).

The system Vascular Insights is developing combines technology licensed from Yale and its own intellectual property in a simplified procedure that uses a single, disposable product for elimination of varicose veins.

According to the founders of Vascular Insights, the company’s procedure will eliminate the need for anesthesia, hospitalization or surgery, and will cause less damage to surrounding tissue and nerves than current therapies. They say this would translate into considerably reduced convalescence, complications and pain for patients.

The featured speakers will be co-founders John Marano, president and CEO of Vascular Insights; and Dr. Michael Tal, chief medical adviser of Vascular Insights and associate professor of radiology at Yale School of Medicine.

Varicose vein disease affects an estimated 75 to 150 million people in North America and Western Europe, and is one of the least treated chronic conditions in the developed world.

“The market for treatment of varicose vein disease is just waiting for a good solution,” said Marano. “Currently only about 1% to 2% of sufferers actually obtain treatment, in large part due to the cost, and the unacceptable nature and trauma of existing treatments — which include surgery and laser destruction of tissue.”

Refreshments and networking will follow the seminar 5-7 p.m. Admission is free, but .advanced registration is required. To RSVP, send an e-mail to biohaven@yale.edu or call the Yale Office of Cooperative Research at (203) 785-6209. A flyer about all events in the series is online at http://curenet.org/download/biohaven.pdf. Directions to the event are available online at http://info.med.yale.edu/maps/cab.html.

Other sponsors of the Yale BioHaven Entrepreneurship Seminars are Wiggin and Dana LLP, Elm Street Ventures, and Price Waterhouse Coopers PC., with support from Yale Entrepreneurial Society and Yale Biotechnology & Pharmaceutical Society.


T H I SW E E K ' SS T O R I E S

Todai-Yale venture to boost Japanese Studies in the U.S.

Yale dedicates $8 million Clean Room

For some infants, mother’s milk can help increase IQ, says study

Engineering lessons get real-world application . . .


ENDOWED PROFESSORSHIPS

School of Public Health launches new Advanced Professional . . .

Shareholder activist creates fund at Yale center for corporate governance

Yale ceremony to commemorate Veteran’s Day

Procrastination is not an option at Dissertation Boot Camp

Show features Chinese artist’s works of ‘Revolution and Rebirth’

IN MEMORIAM

From the United Way: ‘A Tale of Guiding Young Fathers’

Program to look at company developing innovative . . .

Campus Notes


Bulletin Home|Visiting on Campus|Calendar of Events|In the News

Bulletin Board|Classified Ads|Search Archives|Deadlines

Bulletin Staff|Public Affairs|News Releases| E-Mail Us|Yale Home